These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34861106)

  • 1. Immunomodulation of COVID-19 severity by helminth co-infection: Implications for COVID-19 vaccine efficacy.
    Akelew Y; Andualem H; Ebrahim E; Atnaf A; Hailemichael W
    Immun Inflamm Dis; 2022 Mar; 10(3):e573. PubMed ID: 34861106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.
    Naidoo P; Ghazi T; Chuturgoon AA; Naidoo RN; Ramsuran V; Mpaka-Mbatha MN; Bhengu KN; Nembe N; Duma Z; Pillay R; Singh R; Mkhize-Kwitshana ZL
    Environ Int; 2021 Nov; 156():106695. PubMed ID: 34171587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological interactions in helminths-SARS CoV-2 coinfection: Could old enemy be a friend today?
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Elhadad H; Alexiou A; Papadakis M; Ogaly HA; Elgazzar AM; Batiha GE
    Parasite Immunol; 2023 May; 45(5):e12982. PubMed ID: 37038955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants.
    Kayesh MEH; Kohara M; Tsukiyama-Kohara K
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19.
    Lai YJ; Chang HS; Yang YP; Lin TW; Lai WY; Lin YY; Chang CC
    J Chin Med Assoc; 2021 Sep; 84(9):821-826. PubMed ID: 34282078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?
    Cai P; Mu Y; McManus DP
    Front Immunol; 2022; 13():849465. PubMed ID: 35222441
    [No Abstract]   [Full Text] [Related]  

  • 9. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and gut immunomodulation.
    Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
    World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the host immune system by helminth parasites.
    Maizels RM; McSorley HJ
    J Allergy Clin Immunol; 2016 Sep; 138(3):666-675. PubMed ID: 27476889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging issues in COVID-19 vaccination in tropical areas: Impact of the immune response against helminths in endemic areas.
    Chacin-Bonilla L; Chacón-Fonseca N; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 42():102087. PubMed ID: 34051352
    [No Abstract]   [Full Text] [Related]  

  • 14. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection.
    Shenoy S
    Inflamm Res; 2022 Jan; 71(1):13-26. PubMed ID: 34738147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation.
    Fonte L; Acosta A; Sarmiento ME; Ginori M; García G; Norazmi MN
    Front Immunol; 2020; 11():574910. PubMed ID: 33117371
    [No Abstract]   [Full Text] [Related]  

  • 18. Helminth-Tuberculosis Co-infection: An Immunologic Perspective.
    Babu S; Nutman TB
    Trends Immunol; 2016 Sep; 37(9):597-607. PubMed ID: 27501916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
    O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
    Front Immunol; 2021; 12():800723. PubMed ID: 34992610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.
    Jin Y; Hou C; Li Y; Zheng K; Wang C
    Front Immunol; 2021; 12():821538. PubMed ID: 35126377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.